Please ensure Javascript is enabled for purposes of website accessibility

Maryland to share in settlement with drug company Daiichi Sankyo

Maryland will share in the $39 million multistate and federal settlement with pharmaceutical company Daiichi Sankyo over allegations that the firm defrauded government health care programs, the state Office of the Attorney General announced Tuesday. Daiichi allegedly paid kickbacks from 2005 to 2011 to physicians to prescribe its drugs — Azor, Benica, Tribenzor and Wlchol. Maryland’s Medicaid program will receive nearly $43,000, part of which is going to the federal government.